Literature DB >> 11389423

Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid.

J D Raffetto1, M V Mendez, B J Marien, H R Byers, T J Phillips, H Y Park, J O Menzoian.   

Abstract

PURPOSE: Fibroblasts (fb) play an important role in wound healing involving motility, contraction, fibrosis, and expression of the cytoskeletal protein alpha-smooth muscle actin (alpha-sma). Patients with chronic venous insufficiency (CVI) are known to have dermal changes and impaired venous ulcer healing. To investigate whether these dermal-fb have an altered ability to migrate and whether chronic wound fluid from venous ulcers alters neonatal fb motility, we examined cell migration and alpha-sma.
METHODS: Fibroblasts were cultured from the margin of venous ulcers (du-fb, n = 4, CEAP 6), from patients with venous reflux without ulcer (dr-fb, n = 5, CEAP 2), and from the ipsilateral thigh of the same patients with (pu-fb) and without (pr-fb) ulcer, respectively. The abbreviations used are p and d, which represent proximal and distal, respectively; u and r represent ulcer and reflux, respectively. Neonatal foreskin fibroblasts (nf-fb) were exposed to chronic venous ulcer wound fluid (CVUWF, 300 microg protein/mL, n = 3) or bovine serum albumin (BSA, control). Fibroblast motility was determined by means of time-lapse photo-images, and the rate (micrometer per hour) was calculated. Immunohistochemistry for alpha-sma was analyzed with confocal laser microscopy.
RESULTS: The rate of motility (micrometer per hour +/- SEM) was decreased for both du-fb (11.4 +/- 0.7) and dr-fb (13.8 +/- 0.6), when compared with pu-fb (21.9 +/- 0.9) and pr-fb (24.7 +/- 1.1), respectively. The motility rate for nf-fb was lower in CVUWF (24.7 +/- 2.0) than in BSA (37.1 +/- 6.7). An elevated level of microfilament bundles of alpha-sma for both du-fb and dr-fb, compared with those of pu-fb and pr-fb, and also in nf-fb treated with CVUWF was demonstrated by means of immunohistochemistry.
CONCLUSION: These data demonstrate a reduced motility in the dermal fb of patients with CVI. Patients with reflux disease without ulcer are predisposed to these changes. Furthermore, it appears that CVUWF causes changes in motility and alpha-sma expression in nf-fb as demonstrated in du-fb. These findings suggest that reduced motility and CVUWF, representing the microenvironment of venous ulcers, play a significant role in impaired wound healing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389423     DOI: 10.1067/mva.2001.113297

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Wound bed preparation and a brief history of TIME.

Authors:  Gregory S Schultz; David J Barillo; David W Mozingo; Gloria A Chin
Journal:  Int Wound J       Date:  2004-04       Impact factor: 3.315

4.  Soft tissue fibroblasts from well healing and chronic human wounds show different rates of myofibroblasts in vitro.

Authors:  Florian Schwarz; Martina Jennewein; Monika Bubel; Joerg H Holstein; Tim Pohlemann; Martin Oberringer
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 6.  The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.

Authors:  Bruno Amato; Rita Compagna; Maurizio Amato; Lucia Butrico; Francesco Fugetto; Mariia D Chibireva; Andrea Barbetta; Marco Cannistrà; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

Review 7.  Diabetic foot wounds: the value of negative pressure wound therapy with instillation.

Authors:  Luca Dalla Paola
Journal:  Int Wound J       Date:  2013-12       Impact factor: 3.315

8.  Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care.

Authors:  Tatiana N Demidova-Rice; Michael R Hamblin; Ira M Herman
Journal:  Adv Skin Wound Care       Date:  2012-07       Impact factor: 2.347

9.  A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  April E Nedeau; Richard J Bauer; Katherine Gallagher; Haiying Chen; Zhao-Jun Liu; Omaida C Velazquez
Journal:  Exp Cell Res       Date:  2008-04-25       Impact factor: 3.905

10.  Changing the Wound: Covalent Immobilization of the Epidermal Growth Factor.

Authors:  VijayKrishna Raghunathan; Shin Ae Park; Nihar M Shah; Christopher M Reilly; Leandro Teixeira; Richard Dubielzig; Yow-Ren Chang; Monica J Motta; Michael J Schurr; Jonathan F McAnulty; R Rivkah Isseroff; Nicholas L Abbott; Christopher J Murphy
Journal:  ACS Biomater Sci Eng       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.